Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Dr. Shah Nawaz Khan, Shanghai Jiao Tong University, China

Dr. Shah Nawaz Khan, Ph.D. is a distinguished pharmaceutical chemist at Shanghai Jiao Tong University, specializing in organic synthesis, medicinal chemistry, and chemical biology. With a Ph.D. in Pharmaceutical Chemistry, his research spans photocatalytic decarboxylation, transition metal catalysis, and drug discovery. He has led projects on nucleoside antibiotics, shikonin derivatives, and natural product synthesis, contributing to cutting-edge solutions in biomedical innovation. Dr. Khan has an impressive publication record in high-impact journals and actively collaborates on international research initiatives.

Publication Profile

Orcid

Education

Dr. Shah Nawaz Khan 🎓 is a highly accomplished scholar in pharmaceutical sciences. He earned his Ph.D. in Pharmaceutical Chemistry from the School of Pharmacy, Shanghai Jiao Tong University 🇨🇳 (2016–2022). Prior to that, he completed his M.Phil. in Organic Synthesis at the University of Malakand 🇵🇰 (2012–2014), following his Doctor of Pharmacy degree from Gomal University (2004–2009). His academic journey began with an F.Sc. in Pre-Medical (2002–2004) and Matriculation in Science (2001–2002), both from Oxford Education Academy 🏫 in KPK, Pakistan. His strong educational foundation reflects a deep commitment to pharmaceutical research and academic excellence 🔬📚.

Experience

Dr. Shah Nawaz Khan 🔬 has extensive research experience in medicinal and pharmaceutical chemistry. Since Nov 2022, he has been a Postdoctoral Fellow at the School of Chemistry and Chemical Engineering, SJTU 🇨🇳, working on projects like the total synthesis of natural products (GR24), Ullmann coupling, and nucleoside synthesis. His Ph.D. (2016–2022) at SJTU focused on photocatalytic decarboxylative C-O, C-C, and C-N functionalization 🌟, using photoredox and transition metal catalysis. During his M.Phil. (2012–2014) at UOM 🇵🇰, he explored pharmacological activities and synthesized amide derivatives through one-pot reactions. His work bridges synthetic innovation and biological significance 🧪💊.

Awards

Dr. Shah Nawaz Khan 🏅 has been honored with several awards and certificates recognizing his academic, professional, and extracurricular contributions. He received certificates of appreciation for workshops and seminars on faculty development, allied health sciences, and nursing (2020–2022) 🎓. He earned a Personal Protective Equipment Training certificate during the COVID-19 pandemic 🦺 and was awarded the prestigious CSC Type A Scholarship 🇨🇳 in 2016. Earlier, he participated in the “GSK Gold Challenge” (2010), organized national-level declamation contests (2008), and alumni events (2007) 🗣️. Additionally, he holds over 10 sports certificates 🏆, reflecting a well-rounded and active educational journey.

Research Focus

Dr. Shah Nawaz Khan’s research centers on pharmaceutical chemistry and medicinal compound development, particularly emphasizing anticancer, antimicrobial, and antiviral agents. His work explores naphthoquinone derivatives, cyclopeptides, and photocatalytic processes, aiming to discover novel bioactive compounds for drug discovery and skin therapies. Additionally, he contributes to the understanding of molecular mechanisms of action and synthetic methodologies in organic chemistry. His research spans diverse fields including pharmacology, biotechnology, and chemical engineering, reflecting a multidisciplinary approach toward innovative therapeutic solutions. 🌱💊🧬 His cutting-edge investigations significantly impact disease treatment, drug design, and biomedical science.

Publication Top Notes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

A comprehensive study on the effects of annular protrusion for cavitation intensification in Venturi tubes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

Discovery of A Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening

Synthesis and germination activity study of novel strigolactam/strigolactone analogues

Decarboxylative oxidation-enabled consecutive C-C bond cleavage

Decarboxylative oxidation enabled consecutive C-C bond cleavage

Synthesis, characterization and antinociceptive activities of Novel 2-(2,4-dichlorophenyl)-4H-chromen-4-one

Pharmacological Activities and One Pot Two Step Synthesis of Novel (E)-N-(1-methyl-4-oxoimidazolidin-2-ylidene)benzamide

Nigatu Gebrehiwot | Precision Medicine | Best Researcher Award

Published on by Top Pharmaceutical

Nigatu Gebrehiwot | Precision Medicine | Best Researcher Award

Dr. Nigatu Gebrehiwot, Zhengzhou University, China

Dr. Nigatu Gebrehiwot is a dedicated PhD candidate in Pharmacology at Zhengzhou University, China, specializing in drug safety evaluation. He holds a Master’s in Clinical and Administrative Pharmacy from Xi’an Jiaotong University and a Bachelor of Pharmacy from Mekelle University, where he was recognized as an outstanding student. A published researcher and global presenter, Dr. Gebrehiwot has earned accolades including recognition at ISPOR in Barcelona. He is actively involved in multiple international scientific societies and brings strong expertise in pharmacotherapy, academic writing, and collaborative healthcare research. His work explores methionine metabolism and innovative therapeutic strategies.

Publication Profile

Orcid

Education

Dr. Nigatu Gebrehiwot holds a Master’s degree in Clinical and Administrative Pharmacy from Xi’an Jiaotong University, where his research earned an award at the 21st European Congress ISPOR Health Outcome Research Conference in Barcelona, Spain. 🏅 He also earned a Bachelor’s degree in Pharmacy from Mekelle University, where he was recognized as the most outstanding student in his class. 🎓 His academic achievements reflect his dedication to advancing the field of pharmacy, blending clinical expertise with research excellence. Dr. Gebrehiwot’s work continues to impact the healthcare landscape positively.

Experience

Dr. Nigatu Gebrehiwot is currently a Ph.D. candidate in Pharmacology at the Center for Drug Safety Evaluation and Research, Zhengzhou University, Henan, China, since September 2022. 🎓 Prior to this, he served as the Principal Scientific Officer at the Federal Ministry of Health (FMOH) in Ethiopia from June 2020 to 2021. During his tenure, Dr. Gebrehiwot managed national disease programs and medicines, overseeing the funding and evaluation of treatment guidelines and drug therapy protocols in accordance with Ethiopian legislation and EFDA guidelines. 💊 He also led technical committees focused on antimicrobial therapy, cancer, and chronic disease management.

Awards

Dr. Nigatu Gebrehiwot received a prestigious award for his research abstract at the 21st European Congress ISPOR Health Outcome Research conference in Barcelona, Spain. 🏆 This recognition underscores the significant impact of his work in the field of pharmacology and health outcome research. 🌍 His contributions continue to advance knowledge and influence healthcare practices, making him a respected figure in his field. 💡 Dr. Gebrehiwot’s dedication to research excellence and his ability to address critical health issues have earned him well-deserved acknowledgment on an international stage.

Research Focus

Dr. Nigatu Tadesse’s research primarily focuses on molecular alterations in disease processes, with an emphasis on metabolic pathways and their potential as diagnostic and therapeutic targets. His work on gastric intestinal metaplasia and methionine metabolism sheds light on novel approaches to diagnosis and treatment. Additionally, Dr. Tadesse has contributed significantly to pharmacology, particularly the study of traditional medicines like Dioscorea zingiberensis, investigating its phytochemistry, clinical applications, and toxicity. His research also extends to industrial processes, such as wastewater treatment in diosgenin production. His interdisciplinary work connects biomedicine, pharmacology, and environmental science.

Publication Top Notes

Molecular Alterations in Gastric Intestinal Metaplasia Shed Light on Alteration of Methionine Metabolism: Insight into New Diagnostic and Treatment Approaches

Knowledge, attitude and antibiotic prescribing patterns of medical doctors providing free healthcare in the outpatient departments of public hospitals in Sierra Leone: A national cross-sectional study

Dioscorea zingiberensis C. H. Wright: An overview on its traditional use, phytochemistry, pharmacology, clinical applications, quality control, and toxicity

First total synthesis of a novel amide alkaloid derived from Aconitum taipeicum and its anticancer activity

Methods to treat the industrial wastewater in diosgenin enterprises produced from Diosorea zingiberensis C. H. Wright

Safety investigation on total steroid saponins extracts from Dioscorea zingiberensis C.H. Wright: Sub-acute and chronic toxicity studies on dogs

Kyle Frey | Pharmaceutical Manufacturing | Best Researcher Award

Published on by Top Pharmaceutical

Kyle Frey | Pharmaceutical Manufacturing | Best Researcher Award

Mr. Kyle Frey, Quotient Sciences, United States

Mr. Kyle Frey is an exceptionally driven scientist and internationally recognized author with over 12 years of experience in pharmaceutical research and drug development. Specializing in formulation design, preformulation assessments, and manufacturing, he has contributed to advancements in pharmaceutical technologies, including resonant acoustic mixing (RAM) for low-dose blending. Kyle has been honored as a Distinguished Scientist by Marquis Who’s Who and is a sought-after technical expert in the field. With a strong foundation in medical school training at Thomas Jefferson Medical College, he excels in solving complex challenges and advancing innovations in pharmaceutical science.

Publication Profile

Orcid

Education

Kyle Frey pursued an ambitious academic journey, starting with his time at Thomas Jefferson Medical College, where he completed two years of coursework in the M.D. program (08/2010 – 12/2012). Although he did not obtain the degree, his education included in-depth studies in pharmacokinetics, biochemistry, molecular biology, anatomy, neurology, and immunology. Prior to this, he earned a Bachelor of Arts in Pre-Medicine from the University of Delaware (09/2006 – 05/2010), graduating summa cum laude with a 3.942 GPA. He was also a Phi Beta Kappa member, received a full scholarship for his last two years, and earned Dean’s List honors. 🎓

Experience

Kyle Frey is currently serving as a Formulation Scientist III at Quotient Sciences, where he has been since January 2020. His role involves assessing novel APIs using various characterization techniques such as thermal analysis, solubility, and bulk/physical tests. He leads preformulation activities, including excipient selection, compatibility testing, and stability studies, presenting findings and designing laboratory studies. Kyle also develops and optimizes pharmaceutical formulations, resolves formulation issues, and supports GMP manufacturing for clinical trials. He collaborates with cross-functional teams, prepares technical documents, and mentors junior scientists. His expertise includes working with high-potent molecules. 🔬💊

Research Focus

Kyle Frey’s research focuses on the innovative application of Resonant Acoustic Mixing Technology for enhancing the uniformity of low-dose pharmaceutical blends. This technology aims to streamline the process of blending ultra-low doses of active pharmaceutical ingredients (APIs) in a single-step mixing process, improving precision and reducing potential errors in dosage. His work is crucial in the fields of pharmaceutical engineering, formulation science, and drug delivery systems, where blending efficiency directly impacts drug effectiveness and patient safety. Frey’s contributions are pivotal in advancing pharmaceutical manufacturing technologies..

Publication Top Notes

Sample preparation techniques to enhance uniformity of Low-Dose blends mixed by resonant acoustic mixing technology

Use of Resonant Acoustic Mixing Technology for Ultra-Low-Dose Blending in a Single-Step Mixing Process

Use of Resonant Acoustic Technology for Ultra-Low Dose Blending in a Single-Step Mixing Process

Padmavati Manchikanti | Pharmaceutical Law and Ethics | Best Researcher Award

Published on by Top Pharmaceutical

Padmavati Manchikanti | Pharmaceutical Law and Ethics | Best Researcher Award

Prof. Dr. Padmavati Manchikanti, Indian Institute of Technology Kharagpur, India

Prof. Dr. Padmavati Manchikanti, a Ph.D. in Plant Sciences, brings over 16 years of interdisciplinary expertise bridging biotechnology, pharmaceutical law, and intellectual property. A faculty member at IIT Kharagpur since 2006, her work spans drug regulations, patent law, telemedicine, and medical device policy. She has led government-funded research on herbal therapeutics, metabolic engineering, and immunization policy. With several international patents, a Springer-published book on AI in healthcare, and over 1,600 citations, she remains a driving force in biotech innovation and regulatory science.

Publication Profile

Scopus

Education

Prof. Dr. Padmavati Manchikanti 🌿 holds a Ph.D. in Plant Sciences and brings over four years of biotech industry experience. Since 2006, she has been engaged in teaching and research at IIT Kharagpur 🎓. With more than sixteen years of expertise in pharmaceutical law, regulation ⚖️, and intellectual property rights 📜, her research spans cross-country drug law comparisons, drug regulation implementation in India, clinical trial standards, and patent issues related to pharmaceuticals 💊. Her work also explores patent linkage, biodrug patenting, and the evolving landscape of telemedicine patenting and regulation 📡, making her a leading voice in this vital interdisciplinary field.

Experience

Prof. Dr. Padmavati Manchikanti 🌿 has led several impactful research projects across diverse scientific domains. In 2018, she developed a herbal biodegradable therapeutic dressing for traumatic wound care 🩹, funded by the Department of Science and Technology, GOI. The same year, she evaluated Basella species for antioxidant potential and nutraceutical development 🍃, supported by the Government of West Bengal. Earlier, in 2013, she synthesized and characterized bioactive peptides from honey protein 🍯 under CSIR. She also established the Plant Metabolic Pathways Laboratory 🌱 in 2011 with MHRD support and studied international drug price control mechanisms 💊 in 2009 under the Department of Pharmaceuticals.

Professional Memberships

Prof. Dr. Padmavati Manchikanti 🤝 holds esteemed memberships in several prestigious professional organizations, reflecting her interdisciplinary expertise. She is a member of the Association of Teachers and Researchers in Intellectual Property (ATRIP) 📘 and the International Trademark Association ®️. Her global engagement includes past membership in the World Bioenergy Association 🌍 and active involvement in the Federation of Asian Biotechnology Association (FABA) 🧬. Additionally, she is a member of AFBIC at IIT Kharagpur 🎓. These affiliations highlight her strong commitment to advancing knowledge and collaboration in intellectual property, biotechnology, energy, and innovation.

Research Focus

Prof. Dr. Padmavati Manchikanti’s research primarily focuses on telemedicine, remote patient monitoring, food authenticity, and sustainable extraction techniques. Her work on telemedicine tools explores innovations in remote health monitoring, emphasizing cross-country patent analysis. She also investigates issues like honey adulteration and its authentication, addressing global challenges in food safety and quality. Additionally, her research in green extraction techniques involves ultrasound-assisted methods to extract phenolic components from plants like Basella alba, contributing to sustainable food production and health benefits.

Publication Top Notes

Patenting telemedicine tools: A cross-country analysis of technologies related to remote patient monitoring

Honey Authentication: A review of the issues and challenges associated with honey adulteration

Ultrasound assisted green extraction of phenolic components from Basella alba

Comparative Perspectives on the Protection of Food Geographical Indications in Asian Countries

Zhi-Ming Shao | Precision Medicine | Best Researcher Award

Published on by Top Pharmaceutical

Zhi-Ming Shao | Precision Medicine | Best Researcher Award

Prof. Zhi-Ming Shao, Fudan University Shanghai Cancer Center, China

Prof. Zhi-Ming Shao is a distinguished surgical oncologist and global leader in breast cancer research. A graduate of Shanghai Medical University, he chairs the Department of Breast Surgery at Fudan University Shanghai Cancer Center and directs its Breast Cancer Institute. With extensive postdoctoral experience in the U.S. and over 30 years of academic excellence, Prof. Shao has received numerous national honors, including the Chang Jiang Scholar and China’s Most Beautiful Doctor Award. His groundbreaking research, published in top journals like Nature Genetics and Cancer Cell, has significantly advanced precision oncology and breast cancer therapy worldwide.

Publication Profile

Scopus

Education

Prof. Zhi-Ming Shao began his medical journey at Shanghai Medical University, where he earned his Bachelor of Medicine (1980–1985). Driven by a passion for cancer treatment, he pursued a Residency in Surgical Oncology (1985–1990) at the prestigious Fudan University Shanghai Cancer Center. During this period, he also completed his Doctor of Medicine (M.D.) through a Postgraduate Course in Surgical Oncology (1987–1990) at Shanghai Medical University. His comprehensive education laid a strong foundation for his distinguished career in oncology, combining clinical expertise with academic excellence.

Experience

Prof. Zhi-Ming Shao has undergone extensive professional training and leadership roles in oncology. He began as a Postdoctoral Research Fellow (1990–1991) at Wake Forest University, followed by a role as Research Associate (1991–1995) at the University of Maryland Cancer Center. Returning to China, he became Associate Professor (1996–1998) and then Professor (1998–present) at Fudan University Shanghai Cancer Center. Since 2000, he has chaired the Department of Breast Surgery and became Director of the Breast Cancer Institute (2019–present). He also served as Chairman of the 8th Asian Breast Cancer Association (2010–2012) and is now Honorary Chairman of the China Anti-Cancer Association.

Awards

Prof. Zhi-Ming Shao has received numerous prestigious honors and awards throughout his career. In 1998, he was named one of the first batch of distinguished professors of the Chang Jiang Scholars Program. He was awarded the National Science Fund for Distinguished Young Scholars in 2001 and recognized as a Young and Middle-aged Expert with Outstanding Contributions by the Ministry of Health of China in 2004. His accomplishments include the National Prize of Science and Technology Progress (Grade II) in 2005, the National May Day Labor Medal in 2008, and the Chinese Physician Prize in 2020. He was also honored with the 2023 China’s Most Beautiful Doctor Award.

Research Focus

Prof. Zhi-Ming Shao’s research focuses on breast cancer, particularly in the areas of pathogenesis and treatment strategies. His work explores novel therapeutic approaches, such as targeting specific pathways involved in triple-negative breast cancer (TNBC) and HER2-positive breast cancer, as well as developing targeted imaging agents for improved diagnosis. Prof. Shao has contributed significantly to understanding the molecular mechanisms of breast cancer progression and therapy resistance. His studies involve investigating genetic markers, tumor microenvironment interactions, and new treatment combinations. Overall, his research aims to improve clinical outcomes for breast cancer patients, especially in advanced or resistant cases.

Publication Top Notes

Breast cancer: pathogenesis and treatments

Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer

Pilot Study of Nectin-4–Targeted PET Imaging Agent 68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human

Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial

The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer

O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression

Symptoms Related to Brachial Plexus Neuropathy After Supraclavicular Irradiation and Boost in Breast Cancer

Prognostic value of metabolic signature on 18F-FDGuptake in breast cancer patients after radiotherapy

TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer

jun ou | Nanomedicine | Best Academic Researcher Award

Published on by Top Pharmaceutical

jun ou | Nanomedicine | Best Academic Researcher Award

Prof. Dr. jun ou, Guilin University of Technology , China

Prof. Dr. Jun Ou is a renowned materials scientist specializing in biomaterials and nanotechnology. With a Ph.D. from Sichuan University, he serves as a professor at Guilin University of Technology. His expertise spans degradable bio-metals, upconversion nanomaterials, and smart drug delivery systems. He has served as a visiting scholar in Australia and Germany and has received multiple honors, including the Best Researcher Award 2023. Prof. Ou has published widely in high-impact journals and delivered talks at international conferences, contributing significantly to biomedical material innovation.

Publication Profile

Scopus

Education

Prof. Dr. Jun Ou is a distinguished academic with extensive qualifications in biomaterials and related fields. He earned his Ph.D. in Biomaterials from the University of Sichuan’s School of Materials Science and Engineering, where he studied from 2004 to 2010. Earlier, he completed his M.Sc. in Inorganic Chemistry at Guangxi Normal University between 2001 and 2003. His academic journey began with a Bachelor of Science in Engineering from the University of Science and Technology of Chengdu, where he studied from 1982 to 1986. His diverse academic background has laid a strong foundation for his contributions to the field of biomaterials.

Experience

Prof. Dr. Jun Ou has extensive teaching experience in Science and Engineering. From 2010 to 2022, he taught undergraduate and graduate courses at Guilin University of Technology, including “Introduction to Metallurgical Transmission Principles” and “Degradable Bio-Metal” focusing on novel ophthalmic materials. He designed course curricula, organized lectures, and graded assignments. As a professor, he has shared his expertise in Materials Science, Metallurgy, Physics, Inorganic Chemistry, Thermodynamics, and more, educating students worldwide. In addition, he has held visiting scholar positions, including at the Australian National University and Bundesanstalt für Materialforschung und-prüfung in Germany.

Awards

Prof. Dr. Jun Ou has received numerous prestigious awards and honors throughout his distinguished career. In 2023, he was honored with the Best Researcher Award at the International Research Awards on Advanced Nanomaterials and Nanotechnology. In 2022, he was named the Outstanding Open Science Author of the Year by Wiley-China. He also received the CSC Government of China Scholarship Council award in 2013 for his research project on rare earth nanomaterials and their application in constructing nano carbon monoxide carrier release systems, a three-year project that showcased his innovative contributions to nanotechnology and materials science.

Research Focus

Prof. Dr. Jun Ou is a prominent researcher in the field of luminescent materials and nanophosphors, with a specific focus on upconversion luminescence, optical temperature sensing, and lanthanide-doped materials. His work explores the design and enhancement of rare-earth-doped phosphors like NaYF₄: Yb, Ho and Er³⁺/Tm³⁺ systems for efficient green emission and thermometric applications. He also delves into nanoparticle-mediated nitric oxide delivery for biomedical applications like brain tumors. 🚀 His innovative use of Mn doping and 808 nm NIR excitation advances both materials science and nanomedicine, contributing significantly to next-gen optical sensors and bioimaging technologies.

Publication Top Notes

Synchronous realization of green upconversion emission enhancement and optical temperature sensitivity improvement in phosphors NaYF4: Yb, Ho via Mn doping

Promising lanthanide- NaYbF4:Er3+@NaYbF4:Tm3+ micro-phosphors for highly efficient upconversion luminescence and temperature sensing

Preliminary investigation of nitric oxide release from upconverted nanoparticles excited at 808 nm near-infrared for brain tumors

Corrigendum to “The synthesis of Er3+/Yb3+/K+ triple-doped NaYF4 phosphors and its high sensitivity optical thermometers at low power” J. Alloys Compd. 937 (March) (2023) 168299 (Journal of Alloys and Compounds (2023) 937, (S0925838822046904), (10.1016/j.jallcom.2022.168299))

yang huanzhi | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

yang huanzhi | Pharmacology | Best Researcher Award

Dr. yang huanzhi, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China, China

Dr. Huanzhi Yang is a Ph.D. candidate in Food Science and Engineering at China Agricultural University (2019–2025) 🎓, focusing on food nutrition, natural products, and chronic disease prevention. With a strong academic background from Hunan Agricultural University and Huaihua University, his research spans functional food development, gut health, and antioxidants. He has authored multiple high-impact publications 📝, holds several international patents 🧪, and has collaborated on national food science projects. Recognized for his innovation and excellence, Dr. Yang has received numerous scholarships, awards, and honors 🏆, showcasing his commitment to scientific advancement and food health solutions.

Publication Profile

Scopus

Education

Dr. Yang Huanzhi 🎓 is currently pursuing a Ph.D. in Engineering at China Agricultural University (2019.09–2025.06), specializing in Food Science and Engineering under the guidance of Prof. Xiaojun Liao 🍎. He earned his Master’s degree in Bioengineering from Hunan Agricultural University (2016.09–2018.06), mentored by Prof. Guoping Peng 🧬. Dr. Yang began his academic journey at Huaihua University, where he completed his Bachelor’s degree in Bioengineering (2012.09–2016.06) 📘. With a solid foundation in food and biosciences, his research focuses on advancing food science and nutritional engineering for a healthier future 🌱.

Experience

Dr. Yang Huanzhi’s research focuses on food nutrition and health 🍽️, emphasizing the role of natural products in preventing and controlling chronic diseases 💊. With a passion for improving public well-being, he explores the bioactive components in natural sources 🌿 and their potential in promoting long-term health. His work contributes to the development of functional foods that not only nourish but also serve therapeutic purposes 🥦. By integrating nutritional science with innovative food engineering, Dr. Yang aims to create sustainable, health-promoting dietary solutions for modern lifestyles 🧠❤️. His dedication is shaping the future of preventive nutrition and wellness.

Awards

Dr. Yang Huanzhi has been recognized for his outstanding academic and research achievements 🌟. From 2020 to 2024, he consistently received the “Second Class Scholarship” 🏅 for five consecutive years during his doctoral studies at China Agricultural University. In 2022, he earned the second prize in the 3rd “Xingnong Cup” Innovation and Entrepreneurship Competition 💡. His dedication to safety and responsibility earned him the honorary title of Excellent Laboratory Safety Officer for two consecutive years (2021–2022) 🧪🛡️. Additionally, in 2019, his master’s work was honored with the “Excellent Master’s Thesis” award from Hunan Agricultural University 📜🏆.

Research Focus

Dr. Yang Huanzhi focuses on nutraceuticals, gut microbiota, and inflammation-related diseases. His research delves into how natural plant-based compounds—particularly polyphenols from CiLi (Rosa roxburghii Tratt.)—can modulate the gut microbiota-lipid mediator-immunity axis to alleviate chronic inflammatory conditions such as colitis. 🌿 His work bridges phytochemistry, immunology, and microbiome research, emphasizing the therapeutic potential of functional foods and dietary interventions. 🧫💊 By uncovering the molecular pathways through which CiLi polyphenols influence gut health and immune regulation, Dr. Huanzhi contributes to the advancement of integrative medicine and functional nutrition in disease prevention and treatment.

Publication Top Notes

CiLi (Rosa roxburghii Tratt.) polyphenols improve colitis via gut microbiota-lipid mediator-immunity axis

TRAN CHAUMYTHANH | Medicinal Chemistry | Young Scientist Award

Published on by Top Pharmaceutical

TRAN CHAUMYTHANH | Medicinal Chemistry | Young Scientist Award

Dr. TRAN CHAUMYTHANH, DUYTAN UNIVERSITY, Vietnam

Dr. Chaumy Thanh Tran is a dedicated medical doctor and Ph.D. holder from Hue University of Medicine and Pharmacy, Vietnam. Her groundbreaking research integrates online medical databases and sequencing technologies to explore biomarkers for early disease detection—including diabetes, cardiovascular diseases, stroke, and cancers. She focuses on gene-targeted drug development and CRISPR/Cas9 gene editing. From 2023 to 2025, her work on LncRNA/CircRNA/miRNA/gene/protein-drug networks stands out as a vital resource for molecular biology. With several publications in high-impact journals (SCI, Scopus), Dr. Tran’s innovations aim to elevate human health and therapeutic strategies worldwide.

Publication Profile

Scopus

Education

Dr. Tran Chaumythanh 🎓 is a dedicated medical professional with a strong academic foundation in medicine. She earned her Medical Doctor (MD) degree from Hue University of Medicine and Pharmacy, Vietnam 🏥, where she also pursued and completed her Doctorate (Ph.D.) in the same esteemed institution 📚. With a commitment to advancing healthcare and medical education, Dr. Chaumythanh combines clinical expertise with academic excellence, contributing to both patient care and research innovation. Her journey reflects a passion for medicine and a continuous drive for knowledge, shaping her as a respected figure in Vietnam’s medical and academic communities 🌟.

Research Experience

Dr. Tran Chaumythanh 🔬 is at the forefront of cutting-edge research in molecular biology, leveraging online medical databases and next-generation sequencing technologies to advance modern disease studies. Her work focuses on identifying early biomarkers 🧬 for diabetes, cardiovascular diseases, strokes, and cancers. She also explores gene targets for novel drug development 💊 and utilizes gene-editing tools like CRISPR/Cas9 to correct harmful mutations 🧪. From 2023 to 2025, her investigations delve into the complex interaction networks of LncRNA, CircRNA, miRNA, genes, and proteins, aiming to build a comprehensive knowledge base for future therapeutic innovations and precision medicine 🔗📈.

Research Focus

Dr. Tran ChaumyThanh’s research primarily centers on bioinformatics-driven analysis of latent tuberculosis (TB), with a strong focus on gene and miRNA regulatory networks, immune cell infiltration, and potential drug-gene interactions. Utilizing microarray data analysis, molecular docking, and molecular dynamics simulation, her work aims to identify novel therapeutic targets and unravel complex host-pathogen interactions. This multidisciplinary approach bridges computational biology, immunology, and pharmacology, contributing to precision medicine and effective TB management. 🧪📊🧠 Her research holds promise for developing targeted therapies and improving our understanding of latent TB immune mechanisms.

Publication Top Notes

Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

Dhanpat Sharma | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Dhanpat Sharma | Drug Safety and Risk Management | Best Researcher Award

Dr. Dhanpat Sharma, Central University of Haryana, India

Dr. Dhanpat Sharma is a passionate physicist who recently submitted his Ph.D. thesis at the Central University of Haryana, India, focusing on the generation of magnetic fields during heavy ion collisions. His work bridges theoretical simulations with experimental studies involving low-intensity magnetic fields for environmental applications. He has published extensively on photocatalysis, nanomaterials, and nuclear physics. Dr. Sharma is a recipient of multiple prestigious fellowships, including UGC-CSIR NET-JRF and GATE, and has actively presented his research at national and international conferences. His innovative insights continue to contribute significantly to nuclear and materials science.

Publication Profile

orcid

Education

Dr. Dhanpat Sharma 🎓 is a dedicated physicist currently pursuing his Ph.D. in Physics at the Central University of Haryana, Mahendergarh, India, from August 2019 to April 2025. His research, guided by Prof. Suneel Kumar, focuses on the study of nuclear flow, nuclear stopping, magnetic fields, and their inter-correlations in heavy ion collisions ⚛️. He earned his M.Sc. in Physics from Maharishi Dayanand University, Rohtak, between 2016 and 2018 📘. Prior to that, he completed his B.Sc. in Physics, Chemistry, and Mathematics at Kirori Mal College, University of Delhi 🎓, from 2012 to 2016, laying a strong foundation for his scientific journey.

Experience

Dr. Dhanpat Sharma 💻 has hands-on experience in coding within the Quantum Molecular Dynamics (QMD) and Isospin-dependent Quantum Molecular Dynamics (IQMD) frameworks, which are essential tools for simulating heavy ion collisions at intermediate energies ⚛️. His work involves implementing and modifying simulation codes to analyze nuclear flow, nuclear stopping, and magnetic field effects. Through this expertise, Dr. Sharma has gained a deep understanding of the computational modeling of complex nuclear interactions 🧠. His coding proficiency allows him to conduct high-level theoretical research, contributing significantly to the field of nuclear physics 🔬, and enhancing predictive accuracy in nuclear collision studies.

Awards

Dr. Dhanpat Sharma 🏅 has been recognized for his academic excellence with several prestigious awards and honors. He qualified the UGC-CSIR NET-JRF twice, in December 2018 and July 2019, earning a fellowship for his Ph.D. studies 🎓. Additionally, he cleared the GATE exam in February 2019, further showcasing his strong command in physics 📘. Dr. Sharma also qualified for the IGCAR entrance with an impressive All India Rank of 34 🔬. Demonstrating consistent academic merit, he secured the 4th rank in the Ph.D. entrance test conducted by the University of Delhi, solidifying his position among top research scholars in India 🇮🇳.

Research Focus

Dr. Dhanpat Sharma focuses on magneto-photocatalysis, heavy-ion collision physics, and advanced nanomaterials for energy and environmental applications. His research spans the development of photocatalytic materials like α-γ-Fe₂O₃/rGO for antibiotic degradation 💊, to synthesizing nanocomposites for energy storage ⚡ using waste-derived Fe₃O₄. In nuclear physics, he explores the evolution of magnetic and electromagnetic fields 🧲 during heavy-ion collisions, studying correlations with nuclear stopping and elliptical flow. His interdisciplinary expertise bridges materials science, nuclear theory, and applied nanotechnology 🧪, addressing both sustainable tech and fundamental particle interactions in extreme conditions.

Publication Top Notes

Magnetic field and dissolved oxygen assisted ultra-high photocatalytic activity of α-γ-Fe2O3 heterophase wrapped with rGO sheets for the removal of rifampicin

Waste toner derived Fe3O4 nanoparticles embedment into PANI matrix as an advanced electrode for supercapacitor

Probing the contribution of various mass fragments in the production of magnetic field during heavy ion collisions

Correlation between elliptical flow and nuclear stopping around the transition energy in mid rapidity zone

Influence of symmetry energy on electromagnetic field during heavy-ion collisions
Correlation between magnetic field and nuclear stopping in different rapidity segments during heavy ion collisions
Production of magnetic field due to heavy ion collisions around transition energy

Lingming Kong | Psychopharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Lingming Kong | Psychopharmacology | Best Researcher Award

Prof. Lingming Kong, No. 904th Hospital of Joint Logistic Support Force, China

Prof. Lingming Kong, born in February 1982, is a dedicated Chinese research fellow, mental health counsellor, and psychotherapist specializing in health psychology, health promotion, and psychometrics. He holds a Master’s degree in Theoretical Psychology from Hunan Normal University and serves at the Prevention and Treatment Center for Psychological Diseases, No. 904 Hospital, Changzhou. With rich experience in clinical and academic settings, Prof. Kong has been actively involved in mental health services since 2010. He is also an editor and contributor to several key psychological publications.

Publication Profile

orcid

Education

Prof. Lingming Kong 🎓 holds a Master of Science in Psychology from Hunan Normal University and a Bachelor’s degree in Psychology from Qufu Normal University. With a strong academic foundation rooted in both theoretical and applied psychology 📘, he has demonstrated a lifelong commitment to understanding the complexities of the human mind 🧠. His educational journey reflects a deep passion for mental health, emotional well-being, and psychological research 🔬. Prof. Kong’s academic background has not only equipped him with critical knowledge but also laid the groundwork for his influential contributions to the field of psychology and mental health advocacy 🌟.

Experience

Prof. Lingming Kong 🧑‍🏫 brings over 15 years of rich professional experience in psychology, encompassing roles as a University Lecturer, Research Fellow, Mental Health Counsellor, and Psychotherapist 🧠💼. Throughout his career, he has made significant contributions at esteemed institutions such as No. 102 and No. 904 Hospitals 🏥, where he provided expert psychological care and guidance. His leadership abilities shine through his role as Secretary-General of the Special Committee on Medical Psychology in Changzhou 📋🏅. Prof. Kong’s multifaceted career reflects a deep dedication to advancing mental health services and fostering academic excellence in the psychological sciences 🌟.

Research Focus

Prof. Lingming Kong primarily focuses on neuropsychiatric disorders, with a particular emphasis on Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), and adolescent mental health. His research integrates molecular biomarkers such as lncRNAs and circRNAs, along with probiotics and inflammatory markers like IL-1β and cortisol, to explore novel diagnostic and therapeutic strategies. 🧠🧬 His interdisciplinary work bridges psychiatry, immunology, and molecular biology, offering innovative approaches to understanding and treating mental health disorders, especially in young populations. 👩‍⚕️👨‍🔬 His contributions hold promise for personalized medicine and the future of biomarker-based psychiatric care.

Publication Top Notes

An Alternative Approach to Future Diagnosis: Can Generalized Anxiety Disorder Be Distinguished From Major Depressive Disorder, Healthy People by Differentially Expressed lncRNAs in Peripheral Blood

Correlation Between Family Dysfunction and Nonsuicidal Self-Injury in a Sample of Chinese Adolescents: The Mediating Effect of Alexithymia and circRNA_103636

Effects of Treatment with Probiotics on Cognitive Function and Regulatory Role of Cortisol and IL-1β in Adolescent Patients with Major Depressive Disorder

Treatment effects of probiotics on cognitive function and regulatory role of cortisol, IL-1β in adolescent patients of major depressive disorder